- $88.07m
- $722.67m
- $1.11bn
- 53
- 98
- 75
- 89
Annual cashflow statement for Innovate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -102 | -236 | -42 | -38.9 | -39.7 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 106 | 210 | 9.2 | 6.6 | 3.3 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 35.6 | 209 | -20 | 28.1 | 12.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 61.9 | 222 | -9.5 | 26.5 | 9.1 |
Capital Expenditures | -17.8 | -24.1 | -20.7 | -18.4 | -19 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 180 | -199 | -1.8 | 57.5 | 5.1 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 162 | -223 | -22.5 | 39.1 | -13.9 |
Financing Cash Flow Items | -93.7 | -25.3 | -0.7 | -16.2 | -0.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -205 | 4.3 | 68.1 | -65.3 | -26.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 20.6 | 2.2 | 34.7 | 0.1 | -33 |